Sampre Nutritions Ltd

BSE: 530617

14

total announcements

SAMPRE.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 06 Nov 2026

Market Cap

₹40 Cr

P/E (TTM)

3.8

EPS (TTM)

₹1.13

52W Low

₹4.16

52W High

₹38.95

Dividend Yield

0.00%

Beta

-0.19

Price / Book

0.3

Debt / Equity

16.7

Revenue (TTM)

₹47 Cr

Gross Margin

63.44%

Operating Margin

6.66%

AnnouncementsDiscussion
BSEBoard MeetingResults3d ago

Sampre Nutritions Ltd

Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve unaudited standalone and consolidated financial results of the Company for the second quarter ended 30 September 2026 for the financial year 2026-27.

Sampre Nutritions Ltd has scheduled a Board Meeting on 06 November 2026 to consider and approve the unaudited standalone and consolidated financial results for the second quarter ended 30 September 2026.

Read more →📎 1 attachment
BSEInsider Trading / SASTResults27 Sept 2026

Sampre Nutritions Ltd

Closure of Trading Window for the Second Quarter ended 30 September 2026.

Sampre Nutritions Ltd has announced the closure of its trading window from 01 October 2026 till 48 hours after the declaration of unaudited standalone and consolidated financial results for the second quarter of the financial year 2026-27 ending on 30 September 2026.

Read more →📎 1 attachment
BSEGeneralFundraise25 Sept 2026

Sampre Nutritions Ltd

Allotment of 1770710 fully paid-up equity shares having a face value of INR 5 each at an issue price of INR 42 each, including a premium of INR 37 each, aggregating to INR 7,43,69,820 only upon conversion of unsecured loan, on a preferential basis, to Brahma Gurbani and Meera Gurbani, pursuant to the special resolution passed by the members of the Company on 10 December 2025 and in accordance with the In-Principle Approval granted by BSE Limited ....

Sampre Nutritions Ltd has allotted 1,770,710 equity shares at INR 42 each to Brahma Gurbani and Meera Gurbani on a preferential basis, aggregating to INR 7,43,69,820, upon conversion of unsecured loans.

Read more →📎 1 attachment
BSEAGM/EGMResults4 Sept 2026

Sampre Nutritions Ltd

Proceedings of the 35th AGM conducted through Video Conferencing ("VC") / Other Audio-Visual Mode ("OAVM")

Sampre Nutritions Ltd held its 35th Annual General Meeting (AGM) on September 4, 2026, through video conferencing. The meeting was attended by the directors and senior management, and the members approved the audited financial statements and the reappointment of Vishal Ratan Gurbani as a director. The company also approved a revision in the remuneration payable to Vishal Ratan Gurbani.

Read more →📎 1 attachment
BSEAGM/EGMResults14 Aug 2026

Sampre Nutritions Ltd

The company has dispatched the letter to all the shareholders holding shares of the company in physical form, containing a QR code that provides direct access to the Annual Report available ....

Sampre Nutritions Ltd dispatched letters to shareholders holding physical shares, informing them about the availability of the Annual Report for the financial year 2025-26 on the company's website and the BSE website. The letter also requests shareholders to update their KYC details and dematerialize their physical shares.

Read more →📎 1 attachment
BSEAGM/EGM14 Aug 2026

Sampre Nutritions Ltd

This is a corrigendum to the Notice of the 35th AGM. There was a typographical error in the date of appointment of the scrutinizer. The said error has been rectified. Neither any material ....

Sampre Nutritions Ltd has issued a corrigendum to the Notice of the 35th AGM, correcting a typographical error in the date of appointment of the scrutinizer. The error did not affect the substance of the Notice or any material information in the Annual Report.

Read more →📎 1 attachment
BSEOthersResults10 Aug 2026

Sampre Nutritions Ltd

Annual report of the company for the financial year 2025-26. The intimation for the annual report and the notice of the 35th AGM together has been intimated on 10 August 2026.

Sampre Nutritions Ltd has announced its annual report for the financial year 2025-26, along with the notice of its 35th Annual General Meeting (AGM) to be held on September 4, 2026. The report is being circulated electronically to registered members, and a web link is provided for those without registered email addresses.

Read more →📎 1 attachment
BSEAGM/EGMResults10 Aug 2026

Sampre Nutritions Ltd

Notice of the 35th AGM of the Company to be held on Friday, 04 September 2026, at 11:00 A.M. (IST), through video conferencing ("VC") / other audio-visual means ("OAVM") along with the ....

Sampre Nutritions Ltd has announced the 35th AGM to be held on September 4, 2026, through video conferencing. The meeting will consider the audited financial statements for the year ended March 31, 2026, and the reappointment of Vishal Ratan Gurbani as a director. The company has also announced a revision in the remuneration payable to Gurbani.

Read more →📎 1 attachment
BSECompany UpdateResults7 Aug 2026

Sampre Nutritions Ltd

Newspaper publication of the unaudited standalone and consolidated financial results of the company for the first quarter ended 30 June 2026 for the financial year 2026-27.

Sampre Nutritions Ltd has published its unaudited standalone and consolidated financial results for the first quarter ended 30 June 2026, as per Regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment